Search

Your search keyword '"Hsu, Hui Ting"' showing total 160 results
Start Over Author "Hsu, Hui Ting" Publication Year Range Last 10 years
160 results on '"Hsu, Hui Ting"'

1. Gestalt Perception: A Game Designed to Explore Players' Gameplay Self-Efficacy and Anxiety Reflected in Their Learning Effects

Author

Hong, Jon-Chao, Hwang, Ming-Yueh, Hsu, Hui-Ting, and Tai, Kai-Hsin

Abstract

Gestalt perception relates to inferring a holistic scene from separate elements. Using this theory, an application game named Gestalt Puzzle was designed for students to play by recognizing a few parts of an image to reason the whole image of a particular object. Cognitive style can be divided into field independence (FI) and field dependence (FD) depending on individuals' ability to identify minor components of a whole image. To understand the gameplay learning effect, this study explored how players' field-independent cognitive style (FI-CS) interacted with their gameplay performance as the two types of cognitive styles were mediated by their self-efficacy and gameplay anxiety in a competition setting. Data from 112 sixth-grade students were collected for confirmatory factor analysis with structural equation modeling. First, participants completed a trial to familiarize themselves with the functions and mechanism of the game; second, all of the participants were divided into teams to compete against each other for 15 minutes by identifying Chinese paintings; they then completed a questionnaire. The results of this study indicated that FI-CS was positively related to gameplay self-efficacy, but negatively related to gameplay anxiety; perceived utility value could be positively predicted by gameplay self-efficacy, but negatively predicted by gameplay anxiety; and perceived value was positively related to game performance. Moreover, FI-CS was positively related to perceived value mediated by gameplay self-efficacy and gameplay anxiety. The implication of this study is that the Gestalt perception game may engage FI-CS learners with higher levels of gameplay self-efficacy, perceived value, and performance, but a lower level of gameplay anxiety. The present study findings imply that teachers can use Gestalt perception games to promote students' learning of Taiwanese culture.

Published
2023
Full Text
View/download PDF

4. Specifying the Anterior Primitive Streak by Modulating YAP1 Levels in Human Pluripotent Stem Cells

Author

Hsu, Hui-Ting, Estarás, Conchi, Huang, Ling, and Jones, Katherine A

Subjects
Biochemistry and Cell Biology, Biological Sciences, Genetics, Stem Cell Research - Embryonic - Human, Regenerative Medicine, Stem Cell Research, Cardiovascular, Underpinning research, 1.1 Normal biological development and functioning, Activins, Adaptor Proteins, Signal Transducing, Cell Differentiation, Cell Lineage, Cellular Reprogramming, Dasatinib, Endoderm, Human Embryonic Stem Cells, Humans, Myocardium, Myocytes, Cardiac, Phosphoproteins, Pluripotent Stem Cells, Primitive Streak, Transcription Factors, YAP-Signaling Proteins, ACTIVIN, YAP, cardiomyocyte differentiation, human embryonic stem cells, iPSC, primitive streak, Clinical Sciences, Biochemistry and cell biology
Abstract

Specifying the primitive streak (PS) guides stem cell differentiation in vitro; however, much remains to be learned about the transcription networks that direct anterior and posterior PS cells (APS and PPS, respectively) to differentiate to distinct mesendodermal subpopulations. Here, we show that APS genes are predominantly induced in YAP1-/- human embryonic stem cells (hESCs) in response to ACTIVIN. This finding establishes the Hippo effector YAP1 as a master regulator of PS specification, functioning to repress ACTIVIN-regulated APS genes in hESCs. Moreover, transient exposure of wild-type hESCs to dasatinib, a potent C-SRC/YAP1 inhibitor, enables differentiation to APS-derived endoderm and cardiac mesoderm in response to ACTIVIN. Importantly, these cells can differentiate efficiently to normal beating cardiomyocytes without the cytoskeletal defect seen in YAP1-/- hESC-derived cardiomyocytes. Overall, we uncovered an induction mechanism to generate APS cells using a cocktail of ACTIVIN and YAP1i molecules that holds practical implications for hESC and induced pluripotent stem cell differentiation into distinct mesendodermal lineages.

Published
2018

6. Correlation Between Low Cytoplasmic Expression of XBP1 and the Likelihood of Surviving Hepatocellular Carcinoma

Author

Hsu, Hui Ting, Lin, Yueh Min, Hsing, Ming Tai, Yeh, Kun Tu, Lu, Jeng Wei, Yang, Shun Fa, Hsu, Hui Ting, Lin, Yueh Min, Hsing, Ming Tai, Yeh, Kun Tu, Lu, Jeng Wei, and Yang, Shun Fa

Abstract

BACKGROUND/AIM: Our objectives in this study were to (i) evaluate the clinical significance of X-box-binding protein 1 (XBP1) expression in cases of hepatocellular carcinoma (HCC) and (ii) assess the potential of XBP1 to be used as a prognostic biomarker. PATIENTS AND METHODS: The expression of XBP1 protein in 267 HCC tissue specimens was measured using immunohistochemistry in order to characterize the associations among XBP1 expression, clinicopathological factors and survival outcomes. Survival analysis using follow-up data was used to assess the prognostic value of XBP1 in cases of HCC. Immunohistochemistry revealed a significant decrease in cytoplasmic XBP1 protein expression in HCC tumor tissue. RESULTS: Immunoreactivity results showed that low cytoplasmic XBP1 expression was significantly associated with vascular invasion, as well as poor 5-year overall survival and long-term disease-specific (DSS) and disease-free (DFS) survival rates. Kaplan-Meier survival curves further confirmed a significant association between low cytoplasmic XBP1 protein expression and poor DSS and DFS. Univariate and multivariate analyses revealed that XBP1 expression, tumor differentiation, vascular invasion, tumor stage, and the rate of recurrence were linked to DSS, while low cytoplasmic XBP1 expression remained an independent predictor of poor DSS. Our analysis also revealed that XBP1 expression, tumor differentiation, vascular invasion, and T classification were linked to DFS, while low cytoplasmic XBP1 expression remained an independent predictor of poor DFS. CONCLUSION: Low cytoplasmic XBP1 protein expression may play an important role in the pathogenesis of HCC, which suggests that XBP1 could potentially be targeted to benefit therapeutic strategies for HCC.

Published
2024

13. PRECLINICAL DATA SUPPORTING POTENTIAL EFFICACY OF VERVE-201 - AN INVESTIGATIONAL CRISPR BASE EDITING MEDICINE TARGETING ANGPTL3 - IN PRIMARY HUMAN CELLS, MICE, AND NON-HUMAN PRIMATES

Author

Lee, Richard, primary, Denizio, Jamie, additional, Dutta, Chaitali, additional, Hsu, Hui-Ting, additional, Garrity, Ryan, additional, Pacheco, Alline, additional, Rohde, Ellen, additional, Jayaram, Hari, additional, Kathiresan, Sekar, additional, Bellinger, Andrew, additional, and Khera, Amit V., additional

Published
2023
Full Text
View/download PDF

19. Improved Delivery Performance of n-Butylidenephthalide-Polyethylene Glycol-Gold Nanoparticles Efficient for Enhanced Anti-Cancer Activity in Brain Tumor

Author

Hsing, Ming-Tai, primary, Hsu, Hui-Ting, additional, Chang, Chih-Hsuan, additional, Chang, Kai-Bo, additional, Cheng, Chun-Yuan, additional, Lee, Jae-Hwan, additional, Huang, Chien-Li, additional, Yang, Meng-Yin, additional, Yang, Yi-Chin, additional, Liu, Szu-Yuan, additional, Yen, Chun-Ming, additional, Yang, Shun-Fa, additional, and Hung, Huey-Shan, additional

Published
2022
Full Text
View/download PDF

35. Abstract 2216: Combinational strategy targeting B cell malignancy using iPSC engineered CAR-NK (FT596) and CAR-T cell (FT819) platforms with therapeutic antibody to achieve an effective deep and durable response

Author

Goodridge, Jode P., primary, Reiser, John W., additional, Bjordahl, Ryan, additional, Mandal, Milli, additional, Chang, Chia-wei, additional, Clarck, Raedun, additional, Mahmood, Sajid, additional, Zhu, Huang, additional, Gaidarova, Svetlana, additional, Blum, Robert, additional, Cichocki, Frank, additional, Hsu, Hui-ting, additional, Bonello, Greg, additional, Lee, Tom, additional, Groff, Brian, additional, Mamlberg, Karl-Johan, additional, Walcheck, Bruce, additional, Miller, Jeffrey S., additional, Kaufman, Dan, additional, and Valamehr, Bahram, additional

Published
2020
Full Text
View/download PDF

37. Severe ulcerative esophagitis and colitis induced by crizotinib therapy: A case report

Author

Su, Wei‐Wen, Hsu, Hui‐Ting, and Hsu, Po‐Ke

Abstract

The expression of anaplastic lymphoma kinase (ALK), a target of tyrosine kinase is altered in several kinds of cancer, including in non‐small cell lung cancer (NSCLC). For this reason, the use of crizotinib to treat locally advanced or metastatic ALK‐positive NSCLC was approved by the US Food and Drug Administration in 2011. The reported adverse events during clinical trials with crizotinib included esophageal disorders in 11% of the patients, although none of them experienced severe events. Drug‐induced esophagitis or more severe ulcerations are considerably rare according to the available case reports. We report a patient who presented with severe esophageal ulcers after 2‐year treatment with crizotinib for metastatic, ALK‐positive NSCLC. These clinical conditions improved after education on proper eating habits and an additional prescription of a proton pump inhibitor. Several months later, the patient developed colitis with severe diarrhea, which was successfully controlled with mesalazine without reductions in the dosage of crizotinib. To the best of our knowledge, this is the first published case of successfully treated, consecutive esophageal and colonic ulcers related to crizotinib use. Crizotinib is a widely used targeted therapy for locally advanced or metastatic ALK‐positive NSCLC, and clinicians should keep in mind its severe drug‐related adverse effects such as esophagitis and colitis. Treatment with mesalazine, esomeprazole, and slightly decreasing the dose of crizotinib to 200 mg twice daily will be effective.

Published
2022
Full Text
View/download PDF

42. New‐onset Crohn's disease after interleukin‐17Ainhibitor therapy with secukinumab: A report of an unusual case

Author

Wu, Tung‐Lung, Hsu, Hui‐Ting, Yen, Hsu‐Heng, and Chen, Yang‐Yuan

Abstract

A 32‐year‐old man with a history of arthropathic psoriasis had regular follow‐up checkups and medications to control his arthropathic psoriasis at our rheumatology outpatient department. He had diarrhea for 20 days and visited our gastroenterology outpatient department. On the basis of the colonoscopy findings, a diagnosis of inflammatory bowel disease (Crohn's disease) was made. We reviewed his medical history and found that he had used secukinumab 2 months before. Pathological examination revealed chronic colitis with severe activity, compatible with inflammatory bowel disease. The biologic was shifted from secukinumab to adalimumab. His diarrhea gradually improved in the following 3 months. A follow‐up colonoscopy 6 months after revealed remission of the ileal and colonic ulcers.

Published
2022
Full Text
View/download PDF

44. Modified Lung-RADS Improves Performance of Screening LDCT in a Population with High Prevalence of Non–smoking-related Lung Cancer

Author

Hsu, Hui-Ting, primary, Tang, En-Kuei, additional, Wu, Ming-Ting, additional, Wu, Carol C., additional, Liang, Chia-Hao, additional, Chen, Chi-Shen, additional, Mar, Guang-Yuan, additional, Lai, Ruay-Sheng, additional, Wang, Jo-Ching, additional, Wu, Chuan-Ling, additional, Huang, Yi-Luan, additional, and Wu, Fu-Zong, additional

Published
2018
Full Text
View/download PDF

48. Full-Endoscopic Transforaminal Approach for Removal of a Spontaneous Spinal Epidural Hematoma

Author

Chien-Min Chen, Yongjian Zhu, Zong-Yang Wu, Chun-Yuan Cheng, Hsu Hui-Ting, and Lei Chu

Subjects
Adult, Male, medicine.medical_specialty, Percutaneous, medicine.medical_treatment, Lumbar vertebrae, 03 medical and health sciences, 0302 clinical medicine, Lumbar, Back pain, Medicine, Humans, Local anesthesia, 030212 general & internal medicine, Lumbar Vertebrae, business.industry, Laminectomy, Endoscopy, Spinal cord, medicine.disease, Decompression, Surgical, Hematoma, Epidural, Spinal, Magnetic Resonance Imaging, Surgery, medicine.anatomical_structure, Radicular pain, Anesthesia, cardiovascular system, Neurology (clinical), medicine.symptom, business, 030217 neurology & neurosurgery
Abstract

Background The incidence of spinal epidural hematoma (SEH) is estimated to be 1 per 1,000,000 patients per year; SEH can be classified as idiopathic, spontaneous, and secondary. The cause of spontaneous SEH is uncertain but it may be associated with minor trauma. SEH can compress surrounding structures, shown by clinical symptoms and signs that affect the spinal cord or nerve roots. Surgical treatment may be considered if medical treatment fails. Case Description A 26-year-old man presented with lower back pain and significant radicular symptoms on the left side for a week. He denied previous lumbar trauma or the use of anticoagulation drugs. We used the full-endoscopic transforaminal approach (extraforaminal technique) to remove the SEH under local anesthesia. The patient was discharged home 2 days after surgery and the radicular pain disappeared completely. Three months later, follow-up magnetic resonance imaging showed that the dark-brown lesion had been totally removed. Conclusions Spontaneous SEHs are uncommon. Although lumbar laminectomy is the mainstream treatment in those with neurologic deficits caused by epidural hematomas, the percutaneous full-endoscopic transforaminal approach may be an option for certain SEHs.

Published
2016

Catalog

Books, media, physical & digital resources
See catalog results